Remove 2005 Remove Licensing Remove Molecular Biology
article thumbnail

Yesse Technologies secures another grant from The Michael J. Fox Foundation to sniff out Parkinson’s disease

The Pharma Data

Yesse Technologies’ core technology, the ORion21 genetic platform, is the product of over 30 years of fundamental research on the molecular biology of the sense of smell and is exclusively licensed from The City University of New York. This mission is at the core of the Center of Expertise as well. Source link.

Disease 40
article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Chem Immunol Allergy 86:151-183 (2005). Normality sensing licenses local T cells for innate-like tissue surveillance.

Therapies 105
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Nature (2005). Nature (2005).

DNA 90
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Nature (2005).

DNA 52